What top creators are saying about NewLimit
A private biotechnology company focused on epigenetic reprogramming, backed by Brian Armstrong.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Creator sentiment — last 30 days
Not enough scored insights about NewLimit in the last 30 days yet.
Top creators covering NewLimit
The 1 sources with the most insights about NewLimit on Kazuha.
Latest insights about NewLimit
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Friday, December 19, 2025
Mentioned as a key player in the high-potential longevity and age-reversal sector, which is expected to see a major scientific breakthrough.
Friday, December 19, 2025
Mentioned as a key player in the high-potential longevity and age-reversal sector, which is expected to see a major scientific breakthrough.
Discussed alongside NewLimit
Other assets that creators frequently mention in the same content as NewLimit.
Frequently asked
Which podcasters and creators cover NewLimit the most?
The most active sources covering NewLimit on Kazuha are PHD Ventures. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
How many insights about NewLimit are on Kazuha?
Kazuha has indexed 1 AI-extracted insight about NewLimit from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
What other assets do creators discuss alongside NewLimit?
Creators covering NewLimit most frequently also discuss PRIVATE, SPACEX, PRIVATE, FIGAI, Scale AI, Inc.. See the "Discussed alongside" section above for full asset pages.